u/effective_investor · 376d agono track record yet
Finally the new on PSTV!
Plus Therapeutics announced continued progress on the commercial launch of CNSide's CSF tumor cell enumeration diagnostic test, signaling operational execution and revenue potential that should drive upside in the stock.